---
title: "ANAB.US (ANAB.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ANAB.US/news.md"
symbol: "ANAB.US"
name: "ANAB.US"
parent: "https://longbridge.com/en/quote/ANAB.US.md"
datetime: "2026-03-14T08:41:01.860Z"
locales:
  - [en](https://longbridge.com/en/quote/ANAB.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ANAB.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ANAB.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ANAB.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ANAB.US/news.md)


# ANAB.US (ANAB.US) — Related News

### [Wedbush Forecasts Strong Price Appreciation for AnaptysBio (NASDAQ:ANAB) Stock](https://longbridge.com/en/news/278910507.md)
*2026-03-12T15:26:33.000Z*
> Wedbush has raised its target price for AnaptysBio (NASDAQ:ANAB) from $60.00 to $75.00, maintaining an "outperform" rati

### [A Look At AnaptysBio (ANAB) Valuation After Q4 Earnings Turnaround And Jemperli-Linked Milestones](https://longbridge.com/en/news/278275776.md)
*2026-03-08T17:38:47.000Z*
> AnaptysBio (ANAB) reported a Q4 earnings turnaround with a net income of $49.61 million, driven by collaboration revenue

### [What is HC Wainwright's Estimate for AnaptysBio Q1 Earnings?](https://longbridge.com/en/news/278095134.md)
*2026-03-06T12:13:30.000Z*
> HC Wainwright has lowered its Q1 2026 earnings per share estimate for AnaptysBio to ($1.12) from ($1.02). The firm maint

### [Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results](https://longbridge.com/en/news/277999392.md)
*2026-03-05T22:43:00.000Z*
> On March 3, 2026, in San Diego, AnaptysBio, Inc. (Nasdaq: ANAB), a biotechnology company at the clinical stage emphasizi

### [Risks Loom for AnaptysBio’s Proposed Breakup: Market Value, Volatility and Execution Challenges Highlighted](https://longbridge.com/en/news/277898930.md)
*2026-03-05T06:01:33.000Z*
> AnaptysBio (ANAB) faces significant risks regarding its proposed breakup, which may not yield the anticipated operationa

### [Top 10 US Stock Gainers (3.4)](https://longbridge.com/en/news/277838840.md)
*2026-03-04T22:00:51.000Z*
> Babcock & Wilcox(BW) rose 45.68%, with a trading turnover 203.3 Million USD, and a year-to-date rose 86.1%. Day One 

### [](https://longbridge.com/en/news/277834147.md)
*2026-03-04T19:35:43.000Z*
> AnaptysBio shares are trading higher after the company reported better-than-expected Q4 financial results. Also, Barclay

### [BUZZ-U.S. STOCKS ON THE MOVE-Crypto stocks, Lumentum, Babcock & Wilcox Enterprises](https://longbridge.com/en/news/277777712.md)
*2026-03-04T12:20:29.000Z*
### [AnaptysBio Details Plan to Split Into RoyaltyCo and Biopharma at TD Cowen Healthcare Conference](https://longbridge.com/en/news/277816891.md)
*2026-03-04T17:47:21.000Z*
> AnaptysBio (NASDAQ:ANAB) announced plans to split into two publicly traded companies at the TD Cowen Healthcare Conferen

### [BUZZ-AnaptysBio climbs on plans to split into two public companies](https://longbridge.com/en/news/277810200.md)
*2026-03-04T16:27:24.000Z*